Health
Subset of COVID-19 patients have increased bleeding risk – EurekAlert
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
The human body strives to keep itself in homeostasis, or balance. When blood clots are created, the body’s innate response is to break the clots down to prevent significant health problems from arising.
Research has found that patients with COVID-19 are prone to serious blood clotting. This is why many patients receive high dose anticoagulants as part of their treatment.
But a new study in Scientific Reports, led by senior author Daniel Lawrence, Ph.D., a Professor of Basic Research in Cardiovascular…
-
Noosa News20 hours agoPilot left with life-threatening burns to his body as plane crashes to ground in Raglan, Queensland
-
Noosa News14 hours agoTeenage girl killed in house fire in Lawnton, Queensland as police probe potential e-bike link
-
Noosa News23 hours agoBrisbane Lions beat Carlton by 35 points to set up third straight AFLW grand final against Kangaroos
-
Noosa News21 hours agoWhen will my HECS debt be cut? Millions of Australians wake to 20 per cent cut